A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects
Clinical trial NCT05740475 · COMPLETED
Trial details
- NCT number
- NCT05740475
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2023-09-14
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.